{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05831449",
            "orgStudyIdInfo": {
                "id": "CPL-01-302"
            },
            "organization": {
                "fullName": "Cali Pharmaceuticals LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "CPL-01 in the Management of Postoperative Pain After Bunionectomy",
            "officialTitle": "A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy",
            "therapeuticArea": [
                "Other"
            ],
            "study": "cpl-in-the-management-of-postoperative-pain-after-bunionectomy"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-04-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-03",
            "studyFirstSubmitQcDate": "2023-04-25",
            "studyFirstPostDateStruct": {
                "date": "2023-04-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-28",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Cali Pharmaceuticals LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Subjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.",
            "detailedDescription": "After signing informed consent, subjects will be randomly assigned to receive study drug (either Investigational product, positive control, or negative control) during unilateral distal bunionectomy with osteotomy. Subjects will then remain at the hospital for 72-hours where pain and rescue medication usage will be assessed. Follow-up will then occur at 7 and 30 days afterwards.\n\nThe hypothesis is that subjects who receive CPL-01 will have less pain and require fewer opioids than subjects in the other two arms."
        },
        "conditionsModule": {
            "conditions": [
                "Bunion"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 574,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CPL-01",
                    "type": "EXPERIMENTAL",
                    "description": "Local infiltration of study drug",
                    "interventionNames": [
                        "Drug: Local anesthetic injection of CPL-01"
                    ]
                },
                {
                    "label": "Ropivacaine HCl",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Local infiltration of study drug",
                    "interventionNames": [
                        "Drug: Naropin, 0.5% Injectable Solution"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Local infiltration of study drug",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Local anesthetic injection of CPL-01",
                    "description": "Local anesthetic injection (either IP, positive control \\[Naropin\\], or negative control \\[saline placebo\\])",
                    "armGroupLabels": [
                        "CPL-01"
                    ],
                    "otherNames": [
                        "CPL-01",
                        "Long-acting ropivacaine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Naropin, 0.5% Injectable Solution",
                    "description": "Local anesthetic injection (either IP, positive control \\[Naropin\\], or negative control \\[saline placebo\\])",
                    "armGroupLabels": [
                        "Ropivacaine HCl"
                    ],
                    "otherNames": [
                        "ropivacaine HCl"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Local anesthetic injection (either IP, positive control \\[Naropin\\], or negative control \\[saline placebo\\])",
                    "armGroupLabels": [
                        "Placebo"
                    ],
                    "otherNames": [
                        "Saline placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Cumulative Pain Score",
                    "description": "Area Under the Curve of the Numeric Rating Scale Score for Pain with Activity. Activity is resting the operative foot with the ball on the floor. Pain Score spans from 0 to 10, where 0 is no pain and 10 is worst pain imaginable.",
                    "timeFrame": "72 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability to sign ICF\n* Bunion for elective primary unilateral, distal, first metatarsal bunionectomy with osteotomy and internal fixation under regional anesthesia, without collateral procedures or additional surgeries\n* BMI \u2264 39 kg/m2\n* If biologically female, not pregnant or planning to become pregnant over the study\n* If biologically male, either sterile or using acceptable form of birth control\n* Be willing and able to complete study procedures\n\nExclusion Criteria:\n\n* Has previously undergone unilateral simple bunionectomy.\n* Has a planned concurrent surgical procedure\n* Has a concurrent painful condition that may require analgesic treatment during the study period or may confound postsurgical pain assessments\n* Has a history or clinical manifestation of significant medical, neuropsychiatric, or other condition that could preclude or impair study participation or interfere with study assessments.\n* Has a history of malignant hyperthermia or glucose-6-phosphate dehydrogenase deficiency.\n* Has history or evidence of impaired liver function (e.g., alanine aminotransferase \\[ALT\\] \\> 3 \u00d7 upper limit of normal \\[ULN\\] or total bilirubin \\> 2 \u00d7 ULN), active hepatic disease, or cirrhosis.\n* Has history or evidence of impaired renal function (e.g., creatinine \\> 1.5 \u00d7 ULN).\n* Has a history of malignancy in the past year\n* Has known or suspected daily use of opioids for 7 or more consecutive days within the previous 6 months",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Erol Onel",
                    "role": "CONTACT",
                    "phone": "2038376500",
                    "email": "e.onel@calibiosciences.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Erol Onel",
                    "affiliation": "Cali Biosciences",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Todd Bertoch",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Todd Bertoch",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000071378",
                    "term": "Bunion"
                },
                {
                    "id": "D000010149",
                    "term": "Pain, Postoperative"
                }
            ],
            "ancestors": [
                {
                    "id": "D000011183",
                    "term": "Postoperative Complications"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000005531",
                    "term": "Foot Deformities, Acquired"
                },
                {
                    "id": "D000005530",
                    "term": "Foot Deformities"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13069",
                    "name": "Pain, Postoperative",
                    "asFound": "Postoperative Pain",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M783",
                    "name": "Bunion",
                    "asFound": "Bunion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14065",
                    "name": "Postoperative Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M8654",
                    "name": "Foot Deformities",
                    "relevance": "LOW"
                },
                {
                    "id": "M8656",
                    "name": "Foot Deformities, Congenital",
                    "relevance": "LOW"
                },
                {
                    "id": "M8655",
                    "name": "Foot Deformities, Acquired",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077212",
                    "term": "Ropivacaine"
                },
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "asFound": "Traditional",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1700",
                    "name": "Ropivacaine",
                    "asFound": "3 weeks",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "asFound": "Youth",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}